Naloxegol at 25 and 150 mg was not associated with QT/QTc interval prolongation in these healthy men , and at the proposed therapeutic dose of 25 mg/d , naloxegol is not expected to have a clinically relevant effect on cardiac repolarization in patients with OIC .